Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Zydus Cadila gets DCGI approval for Phase Ill trial of ZyCoV-D
The company will now be initiating Phase III clinical trial in around 30,000 volunteers
DCGI approves Covishield and Covaxin for restricted emergency use in India
DCGI’s decision comes after the Subject Expert Committee of CDSCO met on January 1-2, 2021 and recommended the grant of permission…
NSRT to start Phase II trial of Eflornithine granules to treat COVID-19 by early Jan 2021
The company aims to complete the study by March 2021
HMD gets WHO-PQS certification for 0.3 ml Kojak AD Syringe, required for Pfizer’s vaccine
The company supplies to the UN Agencies like UNICEF, UNOPS for and is also manufactures auto disable syringes for curative…
COVAXIN clinical trials recruit 23,000 subjects
COVAXIN has been evaluated in approximately 1000 subjects in Phase I and Phase II clinical trials, with promising safety and…
SEC recommends EUA for Covaxin from Bharat Biotech
The expert panel deliberated on Bharat Biotech’s EUA application after it submitted additional data, facts and analysis after…
Lymphoma drug, pralatrexate outperforms remdesivir against COVID-19: Study
However, this chemotherapy drug can prompt significant side effects so immediate use for COVID-19 patients is not guaranteed, said…
Virtual clinical trials would have a tremendous advantage in expanding the reach of clinical trials
Suneela Thatte, VP and Head - R&D Solutions India, IQVIA speaks on the challenges faced by CROs due to the pandemic, the…
Wallace Pharma sets up R&D Centre in Goa
The facility will have a special focus on new drug delivery systems (NDDS)
Alniche Lifesciences forays into pharma manufacturing as EffiKasia Lifesciences
It will manufacture pharmaceuticals, nutraceuticals and dermatologicals from its facility in Kangra, Himachal Pradesh